Aamer Qazi

1.3k citations
31 papers · 1000 indexed · h-index 19

Aamer Qazi

31 papers receiving 963 citations

Peers

Aamer Qazi
Comparison fields: 5 of 97
  • Complementary and alternative medicine 107
  • Cancer Research 192
  • Reproductive Medicine 72
  • Molecular Biology 521
  • Endocrinology, Diabetes and Metabolism 117
Replace Hee‐Jung Choi with:
Hee‐Jung Choi South Korea
Qingdi Quentin Li China
Yuan Gu China
Ming‐Ting Lee Taiwan
Xiong-Zhi Wu China
Julian C. Desmond United States
Shuwen Yu China
Xiaojie Ma China
Małgorzata Drąg‐Zalesińska Poland
Aamer Qazi relative to Hee‐Jung Choi South Korea Hee‐Jung Choi's profile →
Citations per field
00.5×3.1×
Hee‐Jung Choi · 1×
Citations per year

Countries citing papers authored by Aamer Qazi

Since Specialization
Citations

This map shows the geographic impact of Aamer Qazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aamer Qazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aamer Qazi more than expected).

Fields of papers citing papers by Aamer Qazi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aamer Qazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aamer Qazi. The network helps show where Aamer Qazi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aamer Qazi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aamer Qazi Line = papers co-authored together Aamer Qazi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20208
2 201927
3 20186
4
Improvement in Therapeutic Ability of Wharton's Jelly Derived Mesenchymal Stem Cells with Vitamin E in Breast Cancer.
20172
5 201520
6 201416
7 201491
8 20136
9 201325
10 201226
11 201139
12 201139
13 20114
14 201152
15 201069
16 201058
17 201055
18 200979
19 200127
20 199971

About Aamer Qazi

Aamer Qazi is a scholar working on Cancer Research, Complementary and alternative medicine and Biotechnology, having authored 31 papers that have together received 1000 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (4 papers), RNA modifications and cancer (4 papers), Cancer Research and Treatments (3 papers), Medicinal Plants and Neuroprotection (2 papers), Virus-based gene therapy research (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Complementary and alternative medicine (107 citations), Cancer Research (192 citations) and Reproductive Medicine (72 citations). Aamer Qazi has collaborated with scholars based in United States, Pakistan and Saudi Arabia. Frequent co-authors include Donald W. Weaver, Ramesh B. Batchu, Maria Dufau, Chon‐Hwa Tsai‐Morris, Sanjeev Kumar, Robert Morris, Shelly Seward, Mahmood Rasool, Mahmood Husain Qazi and Christopher S. Bryant. Their work appears in journals such as Molecular and Cellular Biology, Oncogene and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026